HK1183557A1 - Isotope production method - Google Patents

Isotope production method

Info

Publication number
HK1183557A1
HK1183557A1 HK13110818.4A HK13110818A HK1183557A1 HK 1183557 A1 HK1183557 A1 HK 1183557A1 HK 13110818 A HK13110818 A HK 13110818A HK 1183557 A1 HK1183557 A1 HK 1183557A1
Authority
HK
Hong Kong
Prior art keywords
production method
isotope production
isotope
production
Prior art date
Application number
HK13110818.4A
Other languages
English (en)
Chinese (zh)
Inventor
Jan Roger Karlson
Peer Brretzen
Original Assignee
艾爾格塔公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 艾爾格塔公司 filed Critical 艾爾格塔公司
Publication of HK1183557A1 publication Critical patent/HK1183557A1/xx

Links

Classifications

    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005Isotope delivery systems
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001Recovery of specific isotopes from irradiated targets
    • G21G2001/0042Technetium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture And Refinement Of Metals (AREA)
HK13110818.4A 2010-04-30 2013-09-23 Isotope production method HK1183557A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1007353.4A GB201007353D0 (en) 2010-04-30 2010-04-30 Method
PCT/EP2011/002156 WO2011134672A1 (en) 2010-04-30 2011-04-29 Isotope production method

Publications (1)

Publication Number Publication Date
HK1183557A1 true HK1183557A1 (en) 2013-12-27

Family

ID=42289983

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13110818.4A HK1183557A1 (en) 2010-04-30 2013-09-23 Isotope production method

Country Status (21)

Country Link
US (1) US9056142B2 (de)
EP (2) EP2733705A1 (de)
JP (1) JP5969462B2 (de)
KR (1) KR101886883B1 (de)
CN (1) CN102985980B (de)
AU (1) AU2011247362B2 (de)
BR (1) BR112012027945B1 (de)
CA (1) CA2797901C (de)
CY (1) CY1115352T1 (de)
DK (1) DK2564397T3 (de)
EA (1) EA022226B1 (de)
ES (1) ES2473266T3 (de)
GB (1) GB201007353D0 (de)
HK (1) HK1183557A1 (de)
IL (1) IL222764A (de)
MX (1) MX2012012669A (de)
NZ (1) NZ603460A (de)
PL (1) PL2564397T3 (de)
PT (1) PT2564397E (de)
SG (1) SG185106A1 (de)
WO (1) WO2011134672A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201002508D0 (en) 2010-02-12 2010-03-31 Algeta As Product
EP2934545A1 (de) 2012-12-19 2015-10-28 Bayer Pharma Aktiengesellschaft Kombination aus radium-223 zur behandlung von krebs
GB201314718D0 (en) * 2013-08-16 2013-10-02 Algeta As Quantification method
CN105934256B (zh) 2013-12-03 2019-12-27 拜耳制药股份公司 Pi3k-抑制剂的组合产品
EP3077003A1 (de) 2013-12-03 2016-10-12 Bayer Pharma Aktiengesellschaft Kombination von pi3k-inhibitoren
WO2015137451A1 (ja) * 2014-03-13 2015-09-17 株式会社クラレ 重合体、吸着材、並びにその製造方法
AU2015261131B2 (en) * 2014-05-13 2018-02-22 Paul Scherrer Institut Production of 43Sc radionuclide and radiopharmaceuticals thereof for use in Positron Emission Tomography
WO2016083739A1 (fr) 2014-11-26 2016-06-02 Rhodia Operations Composition de lanthane et d'actinium-227
GB201600153D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method
CZ306722B6 (cs) * 2016-03-16 2017-05-24 ÄŚeskĂ© vysokĂ© uÄŤenĂ­ technickĂ© v Praze Způsob izolace Ac ze směsi radia, aktinia a thoria
AU2017312535B2 (en) * 2016-08-16 2021-10-28 Curium Us Llc Chromatographic separation of Mo-99 from W-187
US10704123B2 (en) 2016-08-22 2020-07-07 Uchicago Argonne, Llc Process for the separation and purification of medical isotopes
US10344355B2 (en) * 2016-08-22 2019-07-09 Uchicago Argonne, Llc Process for the separation and purification of scandium medical isotopes
AR110995A1 (es) 2017-02-24 2019-05-22 Bayer Ag Combinación de inhibidores de quinasa atr con sal de radio-223
RU2752845C1 (ru) * 2020-05-13 2021-08-11 Акционерное Общество "Наука И Инновации" Способ получения высокочистого радия-223
CN114873626B (zh) * 2021-12-31 2023-09-19 中国工程物理研究院核物理与化学研究所 一种176Yb2O3和160Gd2O3靶料回收方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390517A (en) 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US5809394A (en) 1996-12-13 1998-09-15 Battelle Memorial Institute Methods of separating short half-life radionuclides from a mixture of radionuclides
JP3832961B2 (ja) * 1998-03-10 2006-10-11 ユニチカ株式会社 ラジウム吸着剤の再生方法
NO310544B1 (no) * 1999-01-04 2001-07-23 Algeta As Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben
JP4380875B2 (ja) * 2000-02-29 2009-12-09 株式会社東芝 液体処理装置
JP2001318087A (ja) * 2000-05-11 2001-11-16 Kawasaki Steel Corp 液体クロマトグラフィー用カラム及びその使用方法
EP1404430B1 (de) * 2001-06-22 2011-10-05 PG Research Foundation, Inc. Automatisiertes system und verfahren zur trennung von radionukliden
JP4740545B2 (ja) * 2002-04-12 2011-08-03 ピージー リサーチ ファンデーション インコーポレイテッド 不純物を含まない所望の娘放射性核種の溶液の製造方法
US7087206B2 (en) * 2002-04-12 2006-08-08 Pg Research Foundation Multicolumn selectivity inversion generator for production of high purity actinium for use in therapeutic nuclear medicine
US7157022B2 (en) * 2002-09-30 2007-01-02 .Pg Research Foundation, Inc. Multivalent metal ion extraction using diglycolamide-coated particles
US20070009409A1 (en) 2005-07-11 2007-01-11 Hariprasad Gali 212Bi or 213Bi Generator from supported parent isotope
ES2504522T3 (es) * 2006-09-08 2014-10-08 Actinium Pharmaceuticals Inc. Método para la purificación de radio a partir de diferentes fuentes
GB201007354D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method

Also Published As

Publication number Publication date
CN102985980A (zh) 2013-03-20
EP2564397B1 (de) 2014-03-19
MX2012012669A (es) 2013-03-08
US20130095031A1 (en) 2013-04-18
ES2473266T3 (es) 2014-07-04
EA022226B1 (ru) 2015-11-30
JP2013533459A (ja) 2013-08-22
DK2564397T3 (da) 2014-06-23
EP2564397A1 (de) 2013-03-06
AU2011247362B2 (en) 2014-11-27
CY1115352T1 (el) 2017-01-04
JP5969462B2 (ja) 2016-08-17
US9056142B2 (en) 2015-06-16
KR20130111930A (ko) 2013-10-11
NZ603460A (en) 2014-09-26
SG185106A1 (en) 2012-12-28
WO2011134672A1 (en) 2011-11-03
CN102985980B (zh) 2015-08-12
EA201291061A1 (ru) 2013-05-30
PT2564397E (pt) 2014-06-25
CA2797901A1 (en) 2011-11-03
BR112012027945A2 (de) 2017-08-15
EP2733705A1 (de) 2014-05-21
IL222764A0 (en) 2012-12-31
KR101886883B1 (ko) 2018-08-08
PL2564397T3 (pl) 2014-10-31
BR112012027945B1 (pt) 2022-07-26
GB201007353D0 (en) 2010-06-16
IL222764A (en) 2016-07-31
CA2797901C (en) 2019-02-26

Similar Documents

Publication Publication Date Title
HK1183557A1 (en) Isotope production method
EP2552873A4 (de) Herstellungsverfahren für hexafluor-2-buten
EP2589573A4 (de) Zeolith-herstellungsverfahren
GB201001833D0 (en) Method
ZA201300297B (en) Isotope production target
EP2722540A4 (de) Stabilisierungsverbindung und herstellungsverfahren dafür
EP2913831A4 (de) Herstellungsverfahren für seltenerdmagneten
HK1225851A1 (zh) 同位素製備方法
HU1000330D0 (en) Novel method
EP2537825A4 (de) Verfahren zur herstellung von 1-amino-1-alkoxycarbonyl-2-vinylcyclopropan
IL223583A (en) A method for the production of quinoline-3-carboxamides
GB201004759D0 (en) Method
EP2722159A4 (de) Struktur und herstellungsverfahren dafür
EP2653482A4 (de) Verfahren zur herstellung von pseudopolyrotaxan
EP2653481A4 (de) Verfahren zur herstellung von pseudopolyrotaxan
PL2760619T3 (pl) Sposób wytwarzania struktury
EP2754508A4 (de) Verfahren zur herstellung eines nahtlosen metallrohres
EP2597178A4 (de) Verfahren zur herstellung von fluorit
EP2752416A4 (de) Neue mangromicinverbindung und herstellungsverfahren dafür
EP2752253A4 (de) Verfahren zur herstellung eines nahtlosen metallrohres
EP2615154A4 (de) Verfahren zur herstellung von beta-sialon
EP2940011A4 (de) Herstellungsverfahren für halohydrantoinverbindung und halohydrantoinverbindung
EP2657222A4 (de) Verfahren zur herstellung einer beta-aminocarbonylverbindung
PL393115A1 (pl) Sposób wytwarzania jogurtu
GB201017043D0 (en) Component production method